In vivo role of TLR2 and MyD88 signaling in eliciting innate immune responses in staphylococcal endophthalmitis

Investigative Ophthalmology and Visual Science

Volumn 56, Issue 3, 2015, Pages 1719-1732

  Talreja, Deepa ^a,b   Singh, Pawan Kumar ^a,c   Kumar, Ashok ^a,b,c,d  

^a WAYNE STATE UNIVERSITY   (United States)

^b OAKLAND UNIVERSITY   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WAYNE STATE UNIVERSITY   (United States)

Author keywords

CRAMP; Endophthalmitis; Inflammation; MyD88; Retinal damage; Staphylococcus aureus; TLR2

Indexed keywords

CHEMOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MYELOID DIFFERENTIATION FACTOR 88; POLYPEPTIDE ANTIBIOTIC AGENT; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE; CYTOKINE; MYD88 PROTEIN, MOUSE; TLR2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL LOAD; CELL INFILTRATION; CHEMOLUMINESCENCE; COLONY FORMING UNIT; CONTROLLED STUDY; DISEASE COURSE; ENDOPHTHALMITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENOTYPING TECHNIQUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INNATE IMMUNITY; MALE; MICROSCOPY; MOUSE; NEUTROPHIL CHEMOTAXIS; NICK END LABELING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RETINA INJURY; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TISSUE INJURY; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; RETINA;

ANIMALS; CATHELICIDINS; CHEMOKINES; CYTOKINES; ENDOPHTHALMITIS; IMMUNITY, INNATE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; RETINA; SIGNAL TRANSDUCTION; STAPHYLOCOCCAL INFECTIONS; TOLL-LIKE RECEPTOR 2;

EID: 84924529735     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.14-16087     Document Type: Article

References (52)

1. Kernt M, Kampik A. Endophthalmitis: pathogenesis, clinical presentation, management, and perspectives. Clin Ophthal-mol. 2010;4:121-135.
2. Kumar A, Singh CN, Glybina IV, Mahmoud TH, Yu FS. Toll-like receptor 2 ligand-induced protection against bacterial endoph-thalmitis. J Infect Dis. 2010;201:255-263.
3. Shamsuddin N, Kumar A. TLR2 mediates the innate response of retinal Muller glia to Staphylococcus aureus. J Immunol. 2011;186:7089-7097.
4. Whiston EA, Sugi N, Kamradt MC, et al. alphaB-crystallin protects retinal tissue during Staphylococcus aureus-induced endophthalmitis. Infect Immun. 2008;76:1781-1790.
5. Callegan M, Gilmore M, Gregory M, et al. Bacterial endoph-thalmitis: therapeutic challenges and host-pathogen interac- tions. Prog Retin Eye Res. 2007;26:189-203.
6. Novosad BD, Callegan MC. Severe bacterial endophthalmitis: towards improving clinical outcomes. Expert Rev Ophthal-mol. 2010;5:689-698.
7. Sadaka A, Durand M, Gilmore M. Bacterial endophthalmitis in the age of outpatient intravitreal therapies and cataract surgeries: host-microbe interactions in intraocular infection. Prog Retin Eye Res. 2012;31:316-331.
8. Yam JC, Kwok AK. Update of the management of postoper- ative endophthalmitis. Hong Kong Med J. 2004;10:337-343.
9. McDonald M, Blondeau JM. Emerging antibiotic resistance in ocular infections and the role of fluoroquinolones. J Cataract Refract Surg. 2010;36:1588-1598.
10. Talreja D, Muraleedharan C, Gunathilaka G, et al. Virulence properties of multidrug resistant ocular isolates of Acineto-bacter baumannii. Curr Eye Res. 2014;39:695-704.
11. Major JC Jr, Engelbert M, Flynn HW Jr, Miller D, Smiddy WE, Davis JL. Staphylococcus aureus endophthalmitis: antibiotic susceptibilities, methicillin resistance, and clinical outcomes. Am J Ophthalmol. 2010;149:278-283.
12. Olson R, Donnenfeld E, Bucci FA Jr, et al. Methicillin resistance of Staphylococcus species among health care and nonhealth care workers undergoing cataract surgery. Clin Ophthalmol. 2010;4:1505-1514.
13. Zaidi T, Yoong P, Pier GB. Staphylococcus aureus corneal infections: effect of the Panton-Valentine leukocidin (PVL) and antibody to PVL on virulence and pathology. Invest Ophthal- mol Vis Sci. 2013;54:4430-4438.
14. Deramo VA, Lai JC, Winokur J, Luchs J, Udell IJ. Visual outcome and bacterial sensitivity after methicillin-resistant Staphylo-coccus aureus-associated acute endophthalmitis. Am J Oph- thalmol. 2008;145:413-417.
15. Callegan MC, Engelbert M, Parke DW II, Jett BD, Gilmore MS. Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions. Clin Microbiol Rev. 2002;15:111-124.
16. Leid JG, Costerton JW, Shirtliff ME, Gilmore MS, Engelbert M. Immunology of staphylococcal biofilm infections in the eye: new tools to study biofilm endophthalmitis. DNA Cell Biol. 2002;21:405-413.
17. Sugi N, Whiston EA, Ksander BR, Gregory MS. Increased resistance to Staphylococcus aureus endophthalmitis in BALB/c mice: Fas ligand is required for resolution of inflammation but not for bacterial clearance. Infect Immun. 2013;81:2217-2225.
18. Callegan MC, Booth MC, Jett BD, Gilmore MS. Pathogenesis of gram-positive bacterial endophthalmitis. Infect Immun. 1999; 67:3348-3356.
19. Kochan T, Singla A, Tosi J, Kumar A. Toll-like receptor 2 ligand pretreatment attenuates retinal microglial inflammatory re-sponse but enhances phagocytic activity toward Staphylococ- cus aureus. Infect Immun. 2012;80:2076-2088.
20. Kumar A, Pandey RK, Miller LJ, Singh PK, Kanwar M. Muller glia in retinal innate immunity: a perspective on their roles in endophthalmitis. Crit Rev Immunol. 2013;33:119-135.
21. Pandey RK, Yu FS, Kumar A. Targeting toll-like receptor signaling as a novel approach to prevent ocular infectious diseases. Indian J Med Res. 2013;138:609-619.
22. Kumar A, Shamsuddin N. Retinal Muller glia initiate innate response to infectious stimuli via Toll-like receptor signaling. PLoS One. 2012;7:e29830.
23. Singh P, Shiha M, Kumar A. Antibacterial responses of retinal Müller glia: production of antimicrobial peptides, oxidative burst and phagocytosis. J Neuroinflammation. 2014;11:33.
24. Rarey KA, Shanks RM, Romanowski EG, Mah FS, Kowalski RP. Staphylococcus aureus isolated from endophthalmitis are hospital-acquired based on Panton-Valentine leukocidin and antibiotic susceptibility testing. J Ocul Pharmacol Ther. 2012; 28:12-16.
25. Ramadan RT, Ramirez R, Novosad BD, Callegan MC. Acute inflammation and loss of retinal architecture and function during experimental Bacillus endophthalmitis. Curr Eye Res. 2006;31:955-965.
26. Talreja D, Kaye KS, Yu FS, Walia SK, Kumar A. Pathogenicity of ocular isolates of Acinetobacter baumannii in a mouse model of bacterial endophthalmitis. Invest Ophthalmol Vis Sci. 2014; 55:2392-2402.
27. Singh PK, Donovan DM, Kumar A. Intravitreal injection of the chimeric phage endolysin Ply187 protects mice from Staph-ylococcus aureus endophthalmitis. Antimicrob Agents Che- mother. 2014;58:4621-4629.
28. Engelbert M, Gilmore MS. Fas ligand but not complement is critical for control of experimental Staphylococcus aureus Endophthalmitis. Invest Ophthalmol Vis Sci. 2005;46:2479-2486.
29. Novosad BD, Astley RA, Callegan MC. Role of Toll-like receptor (TLR) 2 in experimental Bacillus cereus endophthalmitis. PLoS One. 2011;6:e28619.
30. Parkunan SM, Astley R, Callegan MC. Role of TLR5 and flagella in bacillus intraocular infection. PLoS One. 2014;9:e100543.
31. Kumar A, Hazlett LD, Yu FS. Flagellin suppresses the inflammatory response and enhances bacterial clearance in a murine model of Pseudomonas aeruginosa keratitis. Infect Immun. 2008;76:89-96.
32. Sun Y, Hise AG, Kalsow CM, Pearlman E. Staphylococcus aureus-induced corneal inflammation is dependent on Toll-like receptor 2 and myeloid differentiation factor 88. Infect Immun. 2006;74:5325-5332.
33. Hunt JJ, Astley R, Wheatley N, Wang JT, Callegan MC. TLR4 Contributes to the host response to Klebsiella intraocular infection. Curr Eye Res. 2014;39:790-802.
34. Giese MJ, Sumner HL, Berliner JA, Mondino BJ. Cytokine expression in a rat model of Staphylococcus aureus endoph-thalmitis. Invest Ophthalmol Vis Sci. 1998;39:2785-2790.
35. Lacy P, Stow JL. Cytokine release from innate immune cells: association with diverse membrane trafficking pathways. Blood. 2011;118:9-18.
36. Giese MJ, Rayner SA, Fardin B, et al. Mitigation of neutrophil infiltration in a rat model of early Staphylococcus aureus endophthalmitis. Invest Ophthalmol Vis Sci. 2003;44:3077-3082.
37. Yimin, Kohanawa M, Zhao S, et al. Contribution of Toll-like receptor 2 to the innate response against Staphylococcus aureus infection in mice. PLoS One. 2013;8:e74287.
38. Takeuchi O, Hoshino K, Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylo- coccus aureus infection. J Immunol. 2000;165:5392-5396.
39. Callegan MC, Novosad BD, Ramirez R, Ghelardi E, Senesi S. Role of swarming migration in the pathogenesis of bacillus endophthalmitis. Invest Ophthalmol Vis Sci. 2006;47:4461-4467.
40. Talreja D, Muraleedharan C, Gunathilaka G, et al. Virulence properties of multidrug resistant ocular isolates of Acineto-bacter baumannii. Curr Eye Res. 2014;39:695-704.
41. Li Q, Kumar A, Gui JF, Yu FS. Staphylococcus aureus lipoproteins trigger human corneal epithelial innate response through toll-like receptor-2. Microb Pathog. 2008;44:426-434.
42. Pietrocola G, Arciola CR, Rindi S, et al. Toll-like receptors (TLRs) in innate immune defense against Staphylococcus aureus. Int J Artif Organs. 2011;34:799-810.
43. Takeda K, Akira S. TLR signaling pathways. Semin Immunol. 2004;16:3-9.
44. Miller LS, Cho JS. Immunity against Staphylococcus aureus cutaneous infections. Nat Rev Immunol. 2011;11:505-518.
45. Warner N, Núñez G. MyD88: a critical adaptor protein in innate immunity signal transduction. J Immunol. 2013;190:3-4.
46. Kumar A, Gao N, Standiford TJ, Gallo RL, Yu FS. Topical flagellin protects the injured corneas from Pseudomonas aeruginosa infection. Microbes Infect. 2010;12:978-989.
47. Huang LC, Reins RY, Gallo RL, McDermott AM. Cathelicidin-deficient (Cnlp/) mice show increased susceptibility to Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci. 2007;48:4498-4508.
48. Amatngalim GD, Nijnik A, Hiemstra PS, Hancock RE. Cathelicidin peptide LL-37 modulates TREM-1 expression and inflammatory responses to microbial compounds. In- flammation. 2011;34:412-425.
49. Kurosaka K, Chen Q, Yarovinsky F, Oppenheim JJ, Yang D. Mouse cathelin-related antimicrobial peptide chemoattracts leukocytes using formyl peptide receptor-like 1/mouse formyl peptide receptor-like 2 as the receptor and acts as an immune adjuvant. J Immunol. 2005;174:6257-6265.
50. Doss M, White MR, Tecle T, Hartshorn KL. Human defensins and LL-37 in mucosal immunity. J Leukoc Biol. 2010;87:79-92.
51. Alalwani SM, Sierigk J, Herr C, et al. The antimicrobial peptide LL-37 modulates the inflammatory and host defense response of human neutrophils. Eur J Immunol. 2010;40: 1118-1126.
52. Zheng Y, Niyonsaba F, Ushio H, et al. Cathelicidin LL-37 induces the generation of reactive oxygen species and release of human a-defensins from neutrophils. Br J Dermatol. 2007; 157:1124-1131.